$ARRY ARRAY BIOPHARMA INC Insider Trading Week 50/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARRAY BIOPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARRAY BIOPHARMA INC in week 50/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 12,062 | 0 | 36,188 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 11,284 | 0 | 22,570 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | A | 15.97 | 289,500 | 4,623,315 | 289,500 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | A | 0.00 | 48,250 | 0 | 48,250 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Payment of Exercise | F | 15.97 | 10,378 | 165,737 | 235,266 | 245.6 K to 235.3 K (-4.22 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 0.00 | 23,346 | 0 | 245,644 | 222.3 K to 245.6 K (+10.50 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 0.00 | 7,000 | 0 | 21,000 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 0.00 | 5,469 | 0 | 10,938 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | A | 15.97 | 138,000 | 2,203,860 | 138,000 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | A | 0.00 | 23,000 | 0 | 23,000 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Payment of Exercise | F | 15.97 | 5,485 | 87,595 | 68,677 | 74.2 K to 68.7 K (-7.40 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Buy | M | 0.00 | 12,469 | 0 | 74,162 | 61.7 K to 74.2 K (+20.21 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 0.00 | 13,968 | 0 | 41,907 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 0.00 | 13,083 | 0 | 26,166 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | A | 15.97 | 315,750 | 5,042,528 | 315,750 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | A | 0.00 | 52,625 | 0 | 52,625 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Payment of Exercise | F | 15.97 | 11,898 | 190,011 | 174,620 | 186.5 K to 174.6 K (-6.38 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 0.00 | 27,051 | 0 | 186,518 | 159.5 K to 186.5 K (+16.96 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | M | 0.00 | 7,000 | 0 | 21,000 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | A | 15.97 | 116,250 | 1,856,513 | 116,250 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Option Exercise | A | 0.00 | 19,375 | 0 | 19,375 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Payment of Exercise | F | 15.97 | 3,079 | 49,172 | 3,921 | 7 K to 3.9 K (-43.99 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Oltmans Curtis Gale | General Counsel | Buy | M | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 0.00 | 25,000 | 0 | 75,000 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 0.00 | 23,437 | 0 | 46,876 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | A | 0.00 | 678,750 | 0 | 678,750 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | A | 0.00 | 113,125 | 0 | 113,125 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Payment of Exercise | F | 15.97 | 21,303 | 340,209 | 238,709 | 260 K to 238.7 K (-8.19 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 0.00 | 48,437 | 0 | 260,012 | 211.6 K to 260 K (+22.89 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 0.00 | 7,000 | 0 | 21,000 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 0.00 | 4,387 | 0 | 8,766 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | A | 15.97 | 157,500 | 2,515,275 | 157,500 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | A | 0.00 | 26,250 | 0 | 26,250 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Payment of Exercise | F | 15.97 | 5,009 | 79,994 | 41,771 | 46.8 K to 41.8 K (-10.71 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Buy | M | 0.00 | 11,387 | 0 | 46,780 | 35.4 K to 46.8 K (+32.17 %) |